Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythromycin for FAP with APC Nonsense Mutations
NCT02175914Phase 4Unknown
- Start
- Jun 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of erythromycin in familial adenomatous polyposis (FAP). Status: unknown.
02
Drugs
erythromycin
03
Conditions
familial adenomatous polyposis (FAP)
Beyond the preview
Go deeper on NCT02175914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02175914.